Breaking down next generation CAR-T cell therapy: 2025 A year in review

This downloadable clinical aid distils the most significant CAR T therapy developments reported in 2025 for high risk LBCL and relapsed/refractory DLBCL. It brings together key insights from the year’s conference coverage, presenting emerging data, clinical advances, and evolving treatment considerations in a visual format that is free to download and use directly in your clinic.